← Browse by Condition
Medical Condition

pretreated unresectable locally advanced or metastatic her2 breast cancer

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT05458674 Phase 2
Recruiting

Tucatinib+Trastuzumab+Eribulin in HER2+ MBC

Enrollment
30 pts
Location
United States
Sponsor
Criterium, Inc.
View Trial →